Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbusinesswire.com
Business Wire Health: FDA News
Get the latest updates from Business Wire Health: FDA News directly as they happen.
Follow now 108 followers
Latest posts
Last updated 39 minutes ago
Fasikl Receives FDA Clearance for Felix NeuroAI Wristband, the First and Only AI-Powered Treatment for Essential Tremor
39 minutes ago
MINNEAPOLIS--(BUSINESS WIRE)--Fasikl, a trailblazing neuro-AI company redefining the intersection of advanced bioelectronic...
Median Technologies soumet un dossier pour le marquage CE classe II b d’eyonis® LCS, son logiciel dispositif médical basé sur l’Intelligence Artificielle pour le dépistage du cancer du poumon
about 6 hours ago
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, «...
Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS
about 6 hours ago
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible...
REPEAT/Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
about 6 hours ago
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the...
Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
about 9 hours ago
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company...
Fresenius Expands Biosimilars Portfolio With The Launch of Denosumab Biosimilars in the U.S.
about 10 hours ago
LAKE ZURICH, Ill.--(BUSINESS WIRE)-- #CommittedToLife--Fresenius announced today that its operating company Fresenius...
FELIQS announces $9 Million Series A Financing to Advance FLQ-101 Clinical Program for Retinopathy of Prematurity
about 10 hours ago
FUKUOKA, Japan & NEW YORK--(BUSINESS WIRE)--FELIQS Corporation (“FELIQS”), a biotechnology company developing...
Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures
about 20 hours ago
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN) (“Cybin” or the...
Iksuda Therapeutics Receives FDA IND Clearance for IKS014
about 22 hours ago
NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates...
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
about 23 hours ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine...
Neurogene Announces Registrational Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome
1 day ago
NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring...
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content1
1 day ago
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S...